ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P03313


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name POLG_CXB3N
Primary accession number P03313
Secondary accession numbers Q66322 Q66323 Q66324 Q66325 Q66326 Q66327 Q66328 Q83744
Integrated into Swiss-Prot on July 21, 1986
Sequence was last modified on January 23, 2007 (Sequence version 4)
Annotations were last modified on    November 4, 2008 (Entry version 106)
Name and origin of the protein
Protein name Genome polyprotein
Synonyms None
Contains Protein VP0
     (VP4-VP2)
Protein VP4
     (Virion protein 4)
     (P1A)
Protein VP2
     (Virion protein 2)
     (P1B)
Protein VP3
     (Virion protein 3)
     (P1C)
Protein VP1
     (Virion protein 1)
     (P1D)
Picornain 2A
     (Protein 2A)
     (P2A)
     (EC 3.4.22.29)
Protein 2B
     (P2B)
Protein 2C
     (P2C)
     (EC 3.6.1.15)
Protein 3A
     (P3A)
Protein 3B
     (P3B)
     (VPg)
Picornain 3C
     (EC 3.4.22.28)
     (Protease 3C)
     (P3C)
RNA-directed RNA polymerase 3D-POL
     (P3D-POL)
     (EC 2.7.7.48)
Gene name None
From
Coxsackievirus B3 (strain Nancy) [TaxID: 103903] 
Taxonomy Viruses; ssRNA positive-strand viruses, no DNA stage; Picornavirales; Picornaviridae; Enterovirus.
Virus host Homo sapiens (Human) [TaxID: 9606]
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
PubMed=2157045 [NCBI, ExPASy, EBI, Israel, Japan]
Klump W.M., Bergmann I., Mueller B.C., Ameis D., Kandolf R.;
"Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis.";
J. Virol. 64:1573-1583(1990).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
DOI=10.1016/0042-6822(87)90435-1; PubMed=3027968 [NCBI, ExPASy, EBI, Israel, Japan]
Lindberg A.M., Staalhandske P.O.K., Pettersson U.;
"Genome of coxsackievirus B3.";
Virology 156:50-63(1987).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1724-2185.
PubMed=6088796 [NCBI, ExPASy, EBI, Israel, Japan]
Staalhandske P.O.K., Lindberg A.M., Pettersson U.;
"Replicase gene of coxsackievirus B3.";
J. Virol. 51:742-746(1984).
[4]
INTERACTION WITH HOST CD55.
PubMed=7538177 [NCBI, ExPASy, EBI, Israel, Japan]
Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., Barry R.D.;
"Coxsackieviruses B1, B3, and B5 use decay aCCelerating factor as a receptor for cell attachment.";
J. Virol. 69:3873-3877(1995).
[5]
INTERACTION WITH HOST CXADR.
DOI=10.1006/viro.2000.0324; PubMed=10814575 [NCBI, ExPASy, EBI, Israel, Japan]
Martino T.A., Petric M., Weingartl H., Bergelson J.M., Opavsky M.A., Richardson C.D., Modlin J.F., Finberg R.W., Kain K.C., Willis N., Gauntt C.J., Liu P.P.;
"The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.";
Virology 271:99-108(2000).
[6]
FUNCTION OF PROTEIN 3A.
DOI=10.1128/JVI.01225-06; PubMed=17005635 [NCBI, ExPASy, EBI, Israel, Japan]
Wessels E., Duijsings D., Lanke K.H., van Dooren S.H., Jackson C.L., Melchers W.J., van Kuppeveld F.J.;
"Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment.";
J. Virol. 80:11852-11860(2006).
[7]
X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 1-851.
DOI=10.1107/S0907444995002253; PubMed=15299757 [NCBI, ExPASy, EBI, Israel, Japan]
Muckelbauer J.K., Kremer M., Minor I., Tong L., Zlotnick A., Johnson J.E., Rossmann M.G.;
"Structure determination of coxsackievirus B3 to 3.5-A resolution.";
Acta Crystallogr. D 51:871-887(1995).
Comments
  • FUNCTION: Capsid proteins VP1, VP2, VP3 and VP4 form a closed capsid enclosing the viral positive strand RNA genome. VP4 lies on the inner surface of the protein shell formed by VP1, VP2 and VP3. All the three latter proteins contain a beta-sheet structure called beta-barrel jelly roll. Together they form an icosahedral capsid (T=3) composed of 60 copies of each VP1, VP2, and VP3, with a diameter of approximately 300 Angstroms. VP1 is situated at the 12 fivefold axes, whereas VP2 and VP3 are located at the quasi-sixfold axes (By similarity). Capsid proteins interact with host CAR/CXADR or CD55 to provide virion attachment to target cell.
  • FUNCTION: VP0 precursor is a component of immature procapsids (By similarity).
  • FUNCTION: Protein 2A is a cysteine protease that is responsible for the cleavage between the P1 and P2 regions. It cleaves the host translation initiation factor EIF4G1, in order to shut down the capped cellular mRNA transcription (By similarity).
  • FUNCTION: Protein 2B affects membrane integrity and cause an increase in membrane permeability (By similarity).
  • FUNCTION: Protein 2C associates with and induces structural rearrangements of intracellular membranes. It displays RNA-binding, nucleotide binding and NTPase activities (By similarity).
  • FUNCTION: Protein 3A, via its hydrophobic domain, serves as membrane anchor (By similarity). It also inhibits endoplasmic reticulum-to-Golgi transport (By similarity).
  • FUNCTION: Protein 3C is a cysteine protease that generates mature viral proteins from the precursor polyprotein. In addition to its proteolytic activity, it binds to viral RNA, and thus influences viral genome replication. RNA and substrate bind co-operatively to the protease (By similarity).
  • FUNCTION: RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity).
  • CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).
  • CATALYTIC ACTIVITY: Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein.
  • CATALYTIC ACTIVITY: Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
  • CATALYTIC ACTIVITY: NTP + H2O = NDP + phosphate.
  • SUBUNIT: Capsid proteins interact with host CD55 and CXADR.
  • SUBCELLULAR LOCATION: Protein VP2: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein VP3: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein VP1: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein 2B: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 2C: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 3A: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 3B: Virion (Potential).
  • SUBCELLULAR LOCATION: Picornain 3C: Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: RNA-directed RNA polymerase 3D-POL: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • PTM: Specific enzymatic cleavages in vivo by the viral proteases yield a variety of precursors and mature proteins. Polyprotein processing intermediates such as VP0 which is a VP4-VP2 precursor are produced. During virion maturation, non-infectious particles are rendered infectious following cleavage of VP0. This maturation cleavage is followed by a conformational change of the particle (By similarity).
  • PTM: VPg is covalently linked to the genomic RNA (By similarity).
  • PTM: Myristoylation of VP4 is required during RNA encapsidation and formation of the mature virus particle (By similarity).
  • SIMILARITY: Belongs to the picornaviruses polyprotein family.
  • SIMILARITY: Contains 2 peptidase C3 domains [view classification].
  • SIMILARITY: Contains 1 RdRp catalytic domain.
  • SIMILARITY: Contains 1 SF3 helicase domain.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M33854; AAA42931.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
K02709; AAA42932.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M16572; AAA74400.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A26354; GNNYB3.
A34664; GNNYBT.
3D structure databases
PDB
1COV; X-ray; 3.50 A; 4=-.[ExPASy / RCSB / EBI]
3CDU; X-ray; 2.10 A; A=1724-2185.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1COV; -.
3CDU; -.
ModBase P03313.
Ontologies
GO
GO:0031410; Cellular component: cytoplasmic vesicle (inferred from electronic annotation from UniProtKB-KW).
GO:0016020; Cellular component: membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0044419; Biological process: interspecies interaction between organisms (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR003593; AAA+_ATPase_core.
IPR004004; Helicase/Pol/Pept_Calicivir.
IPR000605; Helicase_SF3_ssDNA/RNA_vir.
IPR014759; Helicase_SF3_ssRNA_vir.
IPR014838; P3A.
IPR000199; Pept_C3_picorn.
IPR000081; Peptidase_C3.
IPR003138; Pico_P1A.
IPR002527; Pico_P2B.
IPR001676; Picornavirus_capsid.
IPR001205; RNA_pol_P3D.
IPR007094; RNA_pol_PSvir.
Graphical view of domain structure.
Pfam PF08727; P3A; 1.
PF00548; Peptidase_C3; 1.
PF02226; Pico_P1A; 1.
PF00947; Pico_P2A; 1.
PF01552; Pico_P2B; 1.
PF00680; RdRP_1; 1.
PF00073; Rhv; 3.
PF00910; RNA_helicase; 1.
Pfam graphical view of domain structure.
PRINTS PR00918; CALICVIRUSNS.
ProDom PD001125; Pept_C3_picorn; 1.
PD001306; Peptidase_C3_2; 1.
PD001274; Pico_P2B; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00382; AAA; 1.
SMART graphical view of domain structure.
PROSITE PS50507; RDRP_SSRNA_POS; 1.
PS51218; SF3_HELICASE_2; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS P03313.
ProtoNet P03313.
Other
LinkHub P03313; -.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; ATP-binding; Capsid protein; Complete proteome; Covalent protein-RNA linkage; Cytoplasm; Cytoplasmic vesicle; Helicase; Host-virus interaction; Hydrolase; Lipoprotein; Membrane; Myristate; Nucleotide-binding; Nucleotidyltransferase; Phosphoprotein; Protease; RNA replication; RNA-binding; RNA-directed RNA polymerase; Thiol protease; Transferase; Virion.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
INIT_MET   1      1        Removed; by host (By similarity). 
CHAIN   2    332  331     Protein VP0 (Potential). PRO_0000311047
CHAIN   2     69  68     Protein VP4 (Potential). PRO_0000039582
CHAIN   70    332  263     Protein VP2 (Potential). PRO_0000039583
CHAIN   333    570  238     Protein VP3 (Potential). PRO_0000039584
CHAIN   571    851  281     Protein VP1 (Potential). PRO_0000039585
CHAIN   852   1001  150     Picornain 2A (Potential). PRO_0000039586
CHAIN   1002   1100  99     Protein 2B (Potential). PRO_0000039587
CHAIN   1101   1429  329     Protein 2C (Potential). PRO_0000039588
CHAIN   1430   1518  89     Protein 3A (Potential). PRO_0000039589
CHAIN   1519   1540  22     Protein 3B (Potential). PRO_0000039590
CHAIN   1541   1723  183     Picornain 3C (Potential). PRO_0000039591
CHAIN   1724   2185  462     RNA-directed RNA polymerase 3D-POL (Potential). PRO_0000039592
TOPO_DOM   2   1495  1494     Cytoplasmic (Potential). 
TOPO_DOM   1496   1511  16     In membrane (Potential). 
TOPO_DOM   1512   2185  674     Cytoplasmic (Potential). 
DOMAIN   1205   1361  157     SF3 helicase. 
DOMAIN   1950   2066  117     RdRp catalytic. 
NP_BIND   1229   1236  8     ATP (Potential). 
ACT_SITE   872    872        For picornain 2A activity (By similarity). 
ACT_SITE   890    890        For picornain 2A activity (By similarity). 
ACT_SITE   961    961        For picornain 2A activity (By similarity). 
ACT_SITE   1580   1580        For picornain 3C activity (Potential). 
ACT_SITE   1611   1611        For picornain 3C activity (Potential). 
ACT_SITE   1687   1687        For picornain 3C activity (By similarity). 
SITE   69     70  2     Cleavage (Potential). 
SITE   332    333  2     Cleavage; by picornain 3C (Potential). 
SITE   851    852  2     Cleavage; by picornain 2A (Potential). 
SITE   1001   1002  2     Cleavage; by picornain 3C (Potential). 
SITE   1100   1101  2     Cleavage; by picornain 3C (Potential). 
SITE   1429   1430  2     Cleavage; by picornain 3C (Potential). 
SITE   1518   1519  2     Cleavage; by picornain 3C (Potential). 
SITE   1540   1541  2     Cleavage; by picornain 3C (Potential). 
SITE   1723   1724  2     Cleavage; by picornain 3C (Potential). 
MOD_RES   1521   1521        O-(5'-phospho-RNA)-tyrosine (By similarity). 
LIPID   2      2        N-myristoyl glycine; by host (By similarity). 
CONFLICT   16     16        R -> G (in Ref. 2; AAA74400). 
CONFLICT   177    177        V -> D (in Ref. 2; AAA74400). 
CONFLICT   469    469        P -> L (in Ref. 2; AAA74400). 
CONFLICT   487    487        I -> V (in Ref. 2; AAA74400). 
CONFLICT   510    510        F -> Y (in Ref. 2; AAA74400). 
CONFLICT   516    516        Y -> C (in Ref. 2; AAA74400). 
CONFLICT   566    566        Q -> E (in Ref. 2; AAA74400). 
CONFLICT   593    593        T -> N (in Ref. 2; AAA74400). 
CONFLICT   650    650        K -> E (in Ref. 2; AAA74400). 
CONFLICT   854    865        FGQQSGAVYVGN -> IWTTIRGSVCGD (in Ref. 2; AAA74400). 
CONFLICT   873    873        L -> S (in Ref. 2; AAA74400). 
CONFLICT   1097   1097        A -> P (in Ref. 2; AAA74400). 
CONFLICT   1280   1280        Q -> H (in Ref. 2; AAA74400). 
CONFLICT   1437   1437        I -> F (in Ref. 2; AAA74400). 
CONFLICT   1503   1503        V -> M (in Ref. 2; AAA74400). 
CONFLICT   1616   1616        K -> E (in Ref. 2; AAA74400). 
CONFLICT   1624   1624        R -> G (in Ref. 2; AAA74400). 
CONFLICT   1627   1627        R -> G (in Ref. 2; AAA74400). 
CONFLICT   1630   1630        L -> V (in Ref. 2; AAA74400). 
CONFLICT   1718   1718        Y -> N (in Ref. 2; AAA74400). 
CONFLICT   1734   1734        D -> V (in Ref. 2; AAA74400). 
CONFLICT   1758   1758        E -> V (in Ref. 2 and 3). 
CONFLICT   1824   1824        V -> R (in Ref. 2 and 3). 
CONFLICT   1867   1867        C -> R (in Ref. 2 and 3). 
CONFLICT   1880   1880        Y -> H (in Ref. 2 and 3). 
CONFLICT   2001   2001        D -> N (in Ref. 2 and 3). 
CONFLICT   2095   2095        A -> V (in Ref. 2 and 3). 
CONFLICT   2115   2115        V -> A (in Ref. 2 and 3). 
CONFLICT   2175   2175        S -> T (in Ref. 2 and 3). 
CONFLICT   2178   2178        R -> G (in Ref. 2 and 3). 
STRAND   4      7  4      
STRAND   26     29  4      
HELIX   36     38  3      
TURN   43     44  2      
HELIX   50     52  3      
TURN   53     53  1      
TURN   63     64  2      
TURN   80     81  2      
STRAND   83     87  5      
TURN   88     89  2      
STRAND   90     94  5      
TURN   103    104  2      
TURN   113    115  3      
HELIX   126    128  3      
TURN   129    129  1      
STRAND   133    140  8      
TURN   142    143  2      
STRAND   147    150  4      
TURN   152    154  3      
TURN   156    157  2      
HELIX   159    167  9